BANK VONTOBEL/CALL/ROCHE GS/380/0.02/20.12.24 Share Price

Warrant

WROBKV

CH1225162952

Real-time Bid/Ask 10:55:09 13/05/2024 BST
0.002 CHF / 0.02 CHF -45.00% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/380/0.02/20.12.24
6 months-54.55%
Current year-9.09%

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROBKV
ISINCH1225162952
Date issued 22/11/2022
Strike 380 CHF
Maturity 20/12/2024 (222 Days)
Parity 50 : 1
Emission price 0.17 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.206 CHF
Lowest since issue 0.02 CHF
Delta0.03x
Omega 11.44
Premium67.79x
Gearing412.36x
Moneyness 0.5968
Difference Strike 153.8 CHF
Difference Strike %+40.46%
Spread 0.018 CHF
Spread %90.00%
Theoretical value 0.0110
Implied Volatility 31.90 %
Total Loss Probability 98.48 %
Intrinsic value 0.000000
Present value 0.0110
Break even 380.55 CHF
Theta-0x
Vega0x
Rho0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
  1. Stock Market
  2. Warrants
  3. WROBKV Warrant